Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial
0
Authors
Dong-Jin Park
Dong-Jin Park•Hyemin Jeong•Shin‐Seok Lee
Published
May 24, 2024
Abstract
This study aimed to assess the efficacy and safety of intravenous ramosetron for pain relief in patients with fibromyalgia (FM) unresponsive to conventional treatments.
